Skip to main content
Premium Trial:

Request an Annual Quote

New Products: May 27, 2011


Denator this week launched its Stabilizor Peptide Extraction Kit for the heat-stabilization, homogenization, and extraction of endogenous peptides from tissue samples prior to LC-MS analysis.

The Stabilizor kit is designed to stop tissue degradation at the moment of sampling, preventing the generation of peptide fragments that can contribute to background in studies of endogenous peptides, the company said.

Origene this week made available four new monoclonal antibodies against fluorescent protein tags – Anti-turbo GFP, Anti-enhanced GFP, Anti-turbo YFP, and Anti-turbo RFP.

The antibodies are validated via immunoassays and are optimized for the detection of recombinant fusion proteins, the company said. It is offering $100 anti-tGFP and anti-DDK antibodies with the purchase of a TrueORF clone through May 31.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.